tiprankstipranks
Trending News
More News >
Upstream Bio, Inc. (UPB)
NASDAQ:UPB
US Market

Upstream Bio, Inc. (UPB) Similar Stocks

Compare
157 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Upstream Bio, Inc.
$26.97
$1.50B
-12.15
34.59%
7 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$17.68
$902.48M
31.31
79.13%
4 Buy
1 Hold
0 Sell
Strong Buy
Bicycle Therapeutics
$7.52
$491.38M
-64.77%
6 Buy
3 Hold
0 Sell
Moderate Buy
Prime Medicine, Inc.
$4.33
$756.34M
35.13%
3 Buy
3 Hold
0 Sell
Moderate Buy
Bicara Therapeutics Inc.
$19.11
$1.03B
-5.37%
7 Buy
1 Hold
0 Sell
Strong Buy
Zenas BioPharma, Inc.
$39.10
$2.05B
338.97%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
UPB
Upstream Bio, Inc.
27.47
7.06
34.59%
TBPH
Theravance Biopharma
17.68
7.81
79.13%
BCYC
Bicycle Therapeutics
7.43
-12.68
-63.05%
PRME
Prime Medicine, Inc.
4.27
1.26
41.86%
BCAX
Bicara Therapeutics Inc.
18.85
0.81
4.49%
ZBIO
Zenas BioPharma, Inc.
40.21
30.96
334.70%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts